National Alliance Of State Prostate Cancer Coalitions

In june of 2020, naspcc took over publication of prostatepedia magazine and its weekly digest. Due to expanded coverage and readership, naspcc become even more committed to making prostatepedia the gold standard for men and their families looking for solid, objective, and up-to-date information about prostate cancer. There are currently more than 20,000 subscribers. Naspcc's goals for 2022 include 8 prostatepedia magazines (2 are supplements) on: radiation therapy; theranostics; adt and anti-androgens; testing; genetics, genomics, and prostate cancer; chemotherapy & immunotherapy; imaging; and side effects of treatment. The magazine is archived on naspcc's website (www.naspcc.org), and is downloadable as a pdf. Each magazine issue has interviews with physicians, scientists, and patients.

The access barrier initiative is an effort to remove challenges and barriers for patients in receiving drugs and other treatments prescribed by their physicians but made more difficult or impossible by insurance activities such as step therapy or pre-authorization.

Laminates series, professional fees, and other necessary expenses to further the programs and mission of naspcc.